Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 33 recruiting now early-phase tilt

Acute Kidney Injury: early-phase trial registry

33 of 75 indexed Acute Kidney Injury trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #178 of 28,707 conditions by registered trial count.

75 US clinical trials · 33 currently recruiting · #178 of 28,707 conditions by registered trial count

Acute Kidney Injury: 75 US clinical trials tracked, 33 recruiting.

Acute Kidney Injury is the subject of 75 registered US clinical trials on ClinicalTrials.gov, 33 of them currently open to new participants. 6 are in Phase 3-4 (later-stage) and 22 in Phase 1-2 (earlier-stage). The most active sponsor is Brigham and Women's Hospital, running 3 of these trials.

Enrollment posture brief

Registry condition acute-kidney-injury

OPEN 33 | RECR 44% | LATE 6 | EARLY 22 | RANK #178 | SPON 3

Nearest open-share peer: Acute Lymphoblastic Leukemia (44% recruiting · 132 trials)

Acute Kidney Injury (this)44%Infertility33.3%Age-related Macular Degenera26.7%Tobacco Use Disorder25.3%Pulmonary Disease, Chronic O9.3%
Open-enrollment share among volume-matched conditions near Acute Kidney Injury

Acute Kidney Injury lists 33 open slots (44% of 75 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Acute Kidney Injury on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Acute Kidney Injury is recruiting above its size-band peers.

    33 of 75 indexed trials (44%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Acute Kidney Injury trials is spread across many organizations.

    Brigham and Women's Hospital accounts for 3 of 75 trials (4%). 58 distinct sponsors appear on at least one study for this condition label.

  3. Typical Acute Kidney Injury enrolment sits around 148 participants.

    Median target enrolment is 148 among the 75 trials that report a genuine target (sentinel values excluded). 28 of those (37.3%) plan for fewer than 100 participants.

  4. Acute Kidney Injury splits between interventional and observational designs.

    46 interventional and 29 observational studies make up this index (61.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 16Phase 216Phase 34Phase 42

Open and recent trials

75 total, page 2 of 2

COMPLETED 930 participants

Acute Kidney Injury Neutrophil Gelatinase-Associated Lipocalin Evaluation of Symptomatic Heart Failure Study

Alere San Diego

NCT01291836

COMPLETED 634 participants

The Drug Induced Renal Injury Consortium

Ravindra Mehta

NCT02159209

COMPLETED Phase 2 301 participants

A Safety, Tolerability, Efficacy and QoL Study of Human recAP in the Treatment of Patients With SA-AKI

AM-Pharma

NCT02182440

COMPLETED 252 participants

NGAL As An Aid for the Diagnosis of Acute Kidney Injury in Intensive Care

BioPorto Diagnostics

NCT02121470

COMPLETED 237 participants

Acute Kidney Injury in Premature Infants

University of Alabama at Birmingham

NCT00573079

COMPLETED 150 participants

Evaluation of Catheter Placement for Renal Replacement Therapy in Patients With Acute Kidney Injury

Brigham and Women's Hospital

NCT02200120

COMPLETED Phase 2 150 participants

Activated Vitamin D for the Prevention and Treatment of Acute Kidney Injury

David Leaf

NCT02962102

COMPLETED 148 participants

Assessment of Urinary Neutrophil Gelatinase-Associated Lipocalin to Predict AKI in the NICU

University of Alabama at Birmingham

NCT04354467

COMPLETED 125 participants

Ultrasound Markers of Organ Congestion in Severe Acute Kidney Injury

Centre hospitalier de l'Université de Montréal (CHUM)

NCT04095143

COMPLETED 124 participants

Specimen Stability Study

Astute Medical

NCT01846884

COMPLETED Phase 2 100 participants

Prevention of Post-Cardiac Surgery Acute Kidney Injury by Proton Pump Inhibitor

The University of Texas Health Science Center, Houston

NCT06154226

COMPLETED Phase 3 63 participants

Acute Normovolemic Hemodilution in Complex Cardiac Surgery

University of California, Los Angeles

NCT05049590

COMPLETED Early Phase 1 55 participants

Molecular Effects of Vitamin B3 (Niacinamide) in Acute Kidney Injury

Beth Israel Deaconess Medical Center

NCT02701127

COMPLETED Phase 2 52 participants

The Impact of Ketamine on Postoperative Cognitive Dysfunction, Delirium, and Renal Dysfunction

Mayo Clinic

NCT02554253

COMPLETED Phase 2 47 participants

A Study of OCE-205 in Participants With Cirrhosis With Ascites Who Developed Hepatorenal Syndrome-Acute Kidney Injury

Ocelot Bio

NCT05309200

COMPLETED 41 participants

Intermittent Hypoxemia and Acute Kidney Injury Study (IHAKI Study)

Elie G. Abu Jawdeh, MD

NCT02837276

COMPLETED NA 33 participants

FAST GFR: Pilot Study to Evaluate the Safety of the FAST GFR Test in Patients.

FAST BioMedical

NCT01978314

COMPLETED 32 participants

The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of FAST PV and mGFR Technology™

FAST BioMedical

NCT03095391

COMPLETED Phase 2 30 participants

Fluid Chloride and AKI in Cardiopulmonary Bypass

University of New Mexi

NCT02668952

COMPLETED Phase 2 28 participants

Nicotinamide Riboside in SARS-CoV-2 (COVID-19) Patients for Renal Protection

The University of Texas Health Science Center at San Antonio

NCT04818216

COMPLETED 18 participants

Pharmacokinetics of Antiepileptics in Patients on CRRT

University of Maryland, Baltimore

NCT03632915

COMPLETED Phase 1 16 participants

Pharmacokinetics of MP-3180 and Use of Noninvasive Fluorescence Detection Device in Healthy Volunteers

MediBeacon

NCT02098187

COMPLETED NA 12 participants

Tolerability and Background Fluorescence of the MediBeacon Transdermal GFR Measurement System

MediBeacon

NCT03810833

COMPLETED Phase 1 12 participants

Ibuprofen and Biomarkers of Acute Kidney Injury After Running in the Heat

University of New Mexi

NCT06247462

COMPLETED Phase 1 10 participants

A Study of the PK Interaction of CXA-10 With Pravastatin and Vytorin® in Healthy Males

Complexa

NCT02547402

← Previous Page 2 of 2

Phase Distribution

PhaseTrial count
Phase 1 6
Phase 2 16
Phase 3 4
Phase 4 2

Named interventions

Most-linked intervention names on Acute Kidney Injury records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
7 trials
Physiologically-balanced isotonic crystalloid Other
2 trials
0.9% Saline Other
2 trials
Ketamine Drug
2 trials
Placebo Other
2 trials
AKI Risk Notification Other
1 trials
Calcifediol Drug
1 trials
Iohexol Device
1 trials

US sites by state

Facility locations filed on Acute Kidney Injury trials. A trial with sites in several states counts in each.

California 17 trials
Texas 15 trials
Massachusetts 15 trials
New York 14 trials
Alabama 14 trials
Ohio 13 trials
Michigan 13 trials
Florida 12 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Acute Kidney Injury page

75 registered trials, 33 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Acute Kidney Injury condition card totals 75 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.